Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 140755208

Event date: 2025-04-15

Filing-level shares
780,990.00
Percent of class
8.3%
  • Ronald A. DePinho

    Shares: 780,990.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-015080
Form type
SCHEDULE 13G
Filer
DePinho Ronald A
CIK
CIK 1486420
Filed
Jun 02, 2025
Reporting period
Apr 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub